Education
MD
- University of Pennsylvania Medical School
Publications
- Impact of Simultaneous Circulating Tumor DNA and Tissue Genotyping in the Workup of Stage IV Lung Adenocarcinoma on Quality of Care in an Academic Community Medical Center. Maity AP, Gangireddy M, … Al-Saleem FH, … Dessain SK, Evans TL. JCO Oncol Pract. 2023 Aug;19(8):620-625.
- Phase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non-squamous Non-small Cell Lung Cancer After Progression on Platinum and Pemetrexed. Ciunci CA, Reibel JB, Evans TL, et al. Clin Lung Cancer. 2022 Jun;23(4):e310-e316.
- Optimal prescription isodose line in SBRT for lung tumor treatment with volumetric-modulated arc therapy. Wang D, DeNittis A, Evans T, Meyer T. J Radiosurg SBRT. 2020;7(2):157-164.
- Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 Trial. Rengan R, Mick R, Pryma DA, … Evans TL, et al. JAMA Oncol. 2019 Aug 22. doi: 10.1001/jamaoncol.2019.2095.
- EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes. Marcoux N, Gettinger SN, O'Kane G, … Evans TL, et al. J Clin Oncol. 2019;37(4):278-85.
- Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer. Aggarwal C, Thompson JC, Black TA, … Evans TL, et al. JAMA Oncol. 2019;5(2):173-180.
- Palliative Care in Lung Cancer: When to Start. Bhattacharya P, Dessain SK, Evans TL. Curr Oncol Rep. 2018;20(11):90.